Fibromyalgia and attention deficit hyperactivity disorder

Despite the absence of randomised controlled trial evidence, it remains likely that treating comorbid ADHD improves quality of life, if not FMS directly. The RCP guidelines are aimed at generalists, who are responsible for referring to mental health services: it would be important not to miss a comm...

Full description

Saved in:
Bibliographic Details
Published in:Clinical medicine (London, England) England), 2023-01, Vol.23 (1), p.100-100
Main Authors: Leaver, Laurence, Parry, Allyson, Read, Helen
Format: Article
Language:English
Subjects:
Attention deficit hyperactivity disorder
Autism
Chronic fatigue syndrome
Comorbidity
Family physicians
Fibromyalgia
Hyperactivity
Pain
Post traumatic stress disorder
Quality of life
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite the absence of randomised controlled trial evidence, it remains likely that treating comorbid ADHD improves quality of life, if not FMS directly. The RCP guidelines are aimed at generalists, who are responsible for referring to mental health services: it would be important not to miss a common treatable comorbidity. [...]physicians may be interested to know that ADHD is associated with autonomic dysfunction such as postural orthostatic tachycardia syndrome (POTS), functional bowel disorders, functional urinary disorders such as enuresis, migraine, and other conditions. * LAURENCE LEAVER General practitioner, Jericho Health Centre, Oxford, UK and fellow, Green Templeton College, Oxford University, Oxford, UK ALLYSON PARRY Consultant neurologist, Oxford University Hospitals, Oxford, UK HELEN READ Consultant psychiatrist, London, UK Competing interests Drs Leaver & Parry are affiliated with the UK Adult ADHD Network (UKAAN).
ISSN:1470-2118
1473-4893
DOI:10.7861/clinmed.Let.23.1.3